Lynn Dorsey Bleil insider trades

Open-market stock purchases and sales by Lynn Dorsey Bleil, Unknown at Amicus Therapeutics, Inc, from SEC Form 4 filings since May 6, 2014.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +66%.

Recent trades

DateStockTradeValue
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$1.7M
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$183K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$234K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$238K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$387K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$388K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$385K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$436K
Apr 27, 2026FOLD Amicus Therapeutics, IncSold (not open market)$446K

Companies traded

  • FOLD Amicus Therapeutics, Inc: 1 buy, last Apr 27, 2026
  • SRCL Stericycle Inc: other filings, last Nov 4, 2024
  • DST DST Systems Inc: 1 buy, last Apr 17, 2018
  • ASPX Auspex Pharmaceuticals, Inc: other filings, last May 5, 2015

Get free alerts when Lynn Dorsey Bleil files a new trade →